Monitor future 10-Q and 10-K filings for actual repurchase activity and financial performance. The buyback authorization alone is not a catalyst — execution and fundamental results will determine the stock's trajectory.
Price Chart
Executive Summary
Cosmos Health authorized a $5 million share repurchase program (approximately one-third of its $15M market cap) through December 31, 2026. The filing contains no actual financial data — only forward-looking commentary from management about 'record revenue' and 'improving margins.' The buyback is a capital allocation signal, but without accompanying financial results or guidance, it does not provide a fundamental catalyst.
Key Facts
- Board authorized up to $5 million in share repurchases over 6 months ending December 31, 2026
- Repurchases may be executed via open market, privately-negotiated transactions, or Rule 10b5-1 plans
- CEO cited 'record revenue' and 'improving margins' but no financial figures were disclosed in the filing
- Program size represents ~33% of the company's $15M market cap as of June 29, 2026
Financial Impact
Up to $5 million in share repurchases authorized, representing ~33% of current market capitalization
Risk Factors
- Company may not execute any repurchases depending on market conditions and alternative uses of cash
- No financial data provided — management's forward-looking statements are unverifiable
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001477932-26-004192 |
| Document: cosm_ex991.htm | 0001477932-26-004192 |
| Document: 0001477932-26-004192-index-headers.html | 0001477932-26-004192 |
| Document: 0001477932-26-004192-index.html | 0001477932-26-004192 |
| Document: 0001477932-26-004192.txt | 0001477932-26-004192 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | 8-K | $0.2530 | awaiting T+20 | — | $0.2360 (−6.72%) |
Oct 16, 2026 11d ago | SC 13G/A | $0.3250 | awaiting T+20 | — | $0.2360 (−27.38%) |
Oct 9, 2026 18d ago | 8-K | $0.3496 | awaiting T+20 | — | $0.2360 (−32.49%) |
Sep 3, 2026 7w ago | Press Release | $0.2660 $0.4300 | ▼ −61.65% | ▼ −62.77% | $0.2360 (+11.28%) |
Aug 19, 2026 9w ago | Press Release | $0.1930 | awaiting T+20 | — | $0.2360 (−22.28%) |
Jul 20, 2026 14w ago | Press Release | $0.2303 $0.2050 | ▼ −10.99% | ▼ −15.11% | $0.2360 (+2.48%) |
Jul 17, 2026 14w ago | Press Release | $0.2348 $0.2179 | ▼ −7.20% | ▼ −11.64% | $0.2360 (+0.51%) |
Jul 16, 2026 14w ago | Press Release | $0.2807 $0.2065 | ▼ −26.43% | ▼ −30.05% | $0.2360 (−15.92%) |
Jul 15, 2026 14w ago | Press Release | $0.2785 $0.2071 | ▼ −25.64% | ▼ −27.98% | $0.2360 (−15.26%) |
Jul 14, 2026 15w ago | Press Release | $0.3071 $0.2198 | ▼ −28.43% | ▼ −30.92% | $0.2360 (−23.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers